Trials / Active Not Recruiting
Active Not RecruitingNCT05248737
Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken
Empowering and Transforming the US Broiler Production for Growth, Profit and Sustainability
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (estimated)
- Sponsor
- Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the research is to evaluate if chicken or eggs obtained from chickens that are fed a diet that contains omega-3 fatty acids (DHA/EPA), or vitamin D (as 25(OH)D) provides additional health benefits by improving the status of omega-3 fatty acids or 25(OH)D in healthy adults who eat this bioenhanced chicken or eggs.
Detailed description
The 2015-2020 Dietary Guidelines advocate intake of lean proteins (such as chicken and fish) while limiting intake of saturated fat. Chicken contains similar protein to beef or pork but has less saturated fat. However, chicken, like other terrestrial meats, has little omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) and relatively little vitamin D. Vitamin D insufficiency is common in the US and globally, and has been linked to a number of adverse health outcomes. Vitamin D is ingested primarily from fortified dairy products, but recent animal studies have increased the D content of pork and beef, and the DHA content of chicken and of eggs produced from bioenhanced chickens. Moreover, sunlight exposure alone can enhance the 25(OH)D content of chicken. Notably, supplemental 25(OH)D is more effective than vitamin D at improving vitamin D status in humans, but little is known about the bioavailability of 25(OH)D or DHA/EPA enhanced chicken (muscle) or in enhanced eggs produced from supplemented chickens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | DHA/EPA fortified chicken plus Placebo | For participants who received DHA/EPA fortified chicken |
| DIETARY_SUPPLEMENT | non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement | Provided to participants in the group where they consumed non-fortified chicken/eggs |
| DIETARY_SUPPLEMENT | non-DHA bio-enhanced chicken plus supplement DHA Omega-3 | Used in the crossover part of the study given to the group who did not received DHA bio-enhanced chicken |
| DIETARY_SUPPLEMENT | 25(OH)D bioenhanced chicken and eggs plus placebo | participants will receive 25(OH)D bioenhanced chicken and eggs plus a placebo as a dietary intervention |
| DIETARY_SUPPLEMENT | Dietary Supplement: DHA/EPA fortified eggs plus Placebo | For the participants who received DHA/EPA fortified eggs |
| DIETARY_SUPPLEMENT | non-DHA bio-enhanced eggs plus supplement DHA Omega-3 | for the participants who received non-DHA bio-enhanced eggs plus supplement DHA Omega-3 |
| OTHER | non-25(OH)D fortified chicken/eggs plus placebo | Provided to participants in the group where they consumed non-fortified chicken/eggs + placebo pills |
Timeline
- Start date
- 2021-12-04
- Primary completion
- 2024-12-11
- Completion
- 2026-05-30
- First posted
- 2022-02-21
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05248737. Inclusion in this directory is not an endorsement.